To investigate whether Mapk14 expression can be used as a prognostic marker for colorectal cancer patients, we evaluated the distribution of Mapk14 expression levels and its relationship with patient Disease-free survival (DFS) and Disease Specific Survival (DSS) using the GSE17537 dataset. Here, MAPK14 is linked to colorectal cancer.